Evidence mapPaperPMID 41222994Full record

ReviewKidney3602026

Perspectives on Quality of Life, Vascular Access, and Fluid Balance in Incremental Hemodialysis: A Narrative Review.

Sanne Roos, Thomas S van Lieshout, Alferso C Abrahams, Brigit C van Jaarsveld, Frans J van Ittersum, Erik L Penne

Abstract readReview
In one paragraph

Review in Kidney360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sanne RoosDepartment of Nephrology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID 0009-0004-7225-8542
Thomas S van LieshoutDepartment of Nephrology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-1628-2503
Alferso C AbrahamsDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
Brigit C van JaarsveldDepartment of Nephrology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Frans J van IttersumDepartment of Nephrology, Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-8079-0166
Erik L PenneDepartment of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands.ORCID 0000-0002-6018-4679

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemodialysis is an intensive treatment with a substantial time burden for patients. Generally, a standard hemodialysis schedule consists of three treatments per week, each lasting 4 hours. However, it can be debated whether this schedule is appropriate for all patients. Incremental hemodialysis refers to a treatment approach where hemodialysis is initiated with a less intensive schedule ( i.e ., fewer sessions per week) and gradually increased as residual kidney function declines. The effects of incremental hemodialysis on key outcomes-health-related quality of life, vascular access-related complications, and fluid overload-were discussed in this review. Although incremental hemodialysis is hypothesized to improve health-related quality of life, most studies found no significant difference. Similarly, most studies did not report significant differences in vascular access-related complications. Concerns have been raised regarding fluid overload due to extended intervals between sessions and underdialysis, especially when the transition to a thrice-weekly schedule is delayed. However, most studies found no difference in fluid overload related outcomes. Incremental hemodialysis is a promising, personalized treatment that could reduce the socioeconomic burden of dialysis. Given the methodologic limitations of available studies, ongoing trials will contribute to a clearer understanding of the role of incremental hemodialysis with varying residual kidney function at initiation.

Indexed as

Kidney Failure, ChronicQuality of LifeRenal DialysisWater-Electrolyte BalanceHumansVascular Access Devicesarteriovenous accesschronic hemodialysishemodialysis adequacypatient-centered carevascular access

Identifiers

PMID41222994
PMCPMC12935387

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.